Search results
Moderna Just Gave Investors Another Reason to Buy the Stock
Motley Fool via Yahoo Finance· 3 days agoModerna recently released results from a phase 3 study for its combo coronavirus/flu vaccine. This...
CyanVac secures funding for Phase IIb intranasal Covid-19 vaccine trial
Clinical Trials Arena via Yahoo Finance· 5 days agoThe double-blinded, randomised trial will compare CVXGA's efficacy, safety, and immunogenicity...
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
Benzinga via AOL· 10 hours agoAstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug...
Experts rubbish false claim linking Covid vaccines to HIV cases in southern Philippine city
AFP via Yahoo News· 7 days ago"Vaccine-acquired immunodeficiency syndrome (VAIDS)" -- a term used to refer to a weakened immune...
Fact Check: Study does not say COVID vaccines may have fuelled excess deaths
Reuters· 6 days agoA newly released study does not say COVID-19 vaccines may have fuelled excess deaths across the...
Moderna says new-generation COVID vaccine more effective than Spikevax
Market Watch· 6 days agosaid Thursday a Phase 3 trial of its next-generation COVID-19 vaccine met its main goal and showed...
We Won't Solve Long COVID Until We Decide What It Is
Medscape· 21 hours agoIs a slow recovery from COVID-19 the lingering effects of a bad infection or the start of a new syndrome?
COVID/Flu Experimental Vaccine Receives Positive R | Newswise
Newswise· 2 days agoA vaccine that could offer protection against COVID-19 and the flu has received positive results during trials.According to the drug ...
Novavax seeks FDA nod for updated COVID-19 vaccine By Investing.com
Investing.com· 4 days agoFood and Drug Administration (FDA) for its updated JN.1 COVID-19 vaccine, NVX-CoV2705, for...
Moderna says new-generation COVID vaccine more effective than Spikevax in adults 18 and over
Morningstar· 5 days agoModerna Inc. said Thursday a Phase 3 trial of its next-generation COVID-19 vaccine met its main goal and showed higher efficacy in adults ...